Are you sure you want to exit?
Any unsave changes will be lost.
PATH and WHO
Micro planning
The manufacturer developed high-temperature stability data supporting a license provision permitting up to 4 days out of the cold chain at temperatures up to 40°C
https://www.who.int/immunization/newsroom/events/menafrivac_video/en/